If you’re an issuer of equities, an underwriter, director, officer, broker/dealer, hedge fund manager, or other investment advisor, today’s business climate exposes you to many risks and threats, including regulatory and shareholder actions. Having experienced, strategic, and insightful counsel in your corner is essential to defending your interests. We combine a thorough understanding of your aims with in-depth knowledge of securities law and work with you to determine a sensible, cost-effective strategy for success. When litigation is advisable or necessary, we rigorously represent your interests and provide the highest quality representation—always aligning our approach with your goals.
Knowledge is Power—and Protection.
Our Securities Litigation attorneys deliver excellent results. We are armed with a command of federal and state securities laws and regulations, a dedication to listening to our clients, and a track record of sound judgment and advocacy skills (in and out of the courtroom) that commands widespread recognition. As part of a multi-disciplinary firm, we quickly and efficiently tap into our resources in corporate and tax law, finance, and white collar defense to provide a comprehensive approach to any securities matter.
- Securities fraud class actions
- Shareholder derivative suits
- SEC and state regulatory investigations
- Internal investigations
- Insurance class actions
- FINRA arbitrations
- Whistleblower litigation
- Defense of hedge fund managers and other investment advisors
- Corporate governance and partnership disputes
Hinckley Allen Prevails in $34.5 Million SOX Litigation
Hinckley Allen secured a historic victory with a $34. 5 million recovery in favor of its client, Carlos Domenech Zornoza (Mr. Domenech), marking the culmination of a nine-year legal battle. This is the largest documented recovery for a Sarbanes-Oxley whistl…
Hinckley Allen Representing Royal DSM on $2.6 billion Pharma Transaction
Hinckley Allen is representing Royal DSM, a global life sciences and material sciences company client, in a $2. 6 billion series of transactions that will combine Patheon, Inc. (TSX: PTI) and the DSM Pharmaceutical Products business group into a new company…
Podcast: Jim Tuxbury Talks Whistleblower Litigation on the Great Trials Podcast
October 3, 2025What does it take to win one of the largest Sarbanes-Oxley whistleblower cases to date? In a recent episode of The Great Trials Podcast, Hinckley Allen Litigation Partner Jim Tuxbury sat down with the hosts to share the story behind his $34. 5 million ve…
Podcast: Jim Tuxbury Joins Legal Speak to Discuss Landmark Whistleblower Case
August 21, 2025Hinckley Allen Partner Jim Tuxbury was a guest on ALM’s Legal Speak podcast with host Patrick Smith, where he shared insights from his nine-year legal battle representing Carlos Domenech Zornoza. The case resulted in a $34. 5 million recovery, the largest …
Hinckley Allen's Jim Tuxbury Talks Whistleblower Litigation on the Great Trials Podcast
October 1, 2025What does it take to win one of the largest Sarbanes-Oxley whistleblower cases to date? In a recent episode of The Great Trials Podcast, Hinckley Allen Litigation Partner Jim Tuxbury sat down with the hosts to share the story behind his $34. 5 million verdi…
Hinckley Allen Named a Best Law Firm by Best Lawyers Since 2010
November 2, 2023Best Lawyers has recognized Hinckley Allen as a Best Law Firm for the 14th year in a row. Firms included in the 2024 Best Law Firms list are recognized for professional excellence with persistently impressive ratings from clients and peer…
